184
Views
72
CrossRef citations to date
0
Altmetric
Original Research

Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells

, , , , , , , , , , , , & show all
Pages 2491-2505 | Published online: 23 Apr 2018

References

  • AnjumKShaguftaBIAbbasSQCurrent status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a reviewBiomed Pharmacother20179268168928582760
  • ParasramkaSTalariGRosenfeldMGuoJVillanoJLProcarbazine, lomustine and vincristine for recurrent high-grade gliomaCochrane Database Syst Rev201771CD01177328744879
  • FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
  • Cancer Facts & Figures 2017Atlanta, GAAmerican Cancer Society2017
  • BrandesAATosoniAFranceschiEReniMGattaGVechtCGlioblastoma in adultsCrit Rev Oncol Hematol200867213915218394916
  • GlaserTHanIWuLZengXTargeted nanotechnology in glioblastoma multiformeFront Pharmacol2017816628408882
  • TosiUMarnellCSChangRAdvances in molecular imaging of locally delivered targeted therapeutics for central nervous system tumorsIn J Mol Sci2017182E351
  • ReniMMazzaEZanonSGattaGVechtCJCentral nervous system gliomasCrit Rev Oncol Hematol201711321323428427510
  • SeystahlKPapachristodoulouABurghardtIBiological role and therapeutic targeting of TGF-β3 in glioblastomaMol Cancer Ther20171661177118628377490
  • ZhouJTienACAlbertaJAA sequentially priming phosphorylation cascade activates the gliomagenic transcription factor olig2Cell Rep201718133167317728355568
  • LiYLinTLuoYA smart and versatile theranostic nanomedicine platform based on nanoporphyrinNat Commun20145471225158161
  • Di CoratoRBéalleGKolosnjaj-TabiJCombining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomesACS Nano2015932904291625695371
  • PasparakisGManourasTVamvakakiMArgitisPHarnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo-chemotherapyNat Commun20145362324710504
  • MuXZhangFKongCEGFR-targeted delivery of DOX-loaded Fe3O4@polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapyInt J Nanomedicine2017122899291128435266
  • LianHYHuMLiuCHYamauchiYWuKCWHighly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug deliveryChem Commun (Camb)201248425151515322514015
  • ShiehFKWangSCYenCLImparting functionality to biocatalysts via embedding enzymes into nanoporous materials by a de novo approach: size-selective sheltering of catalase in metal−organic framework microcrystalsJ Am Chem Soc2015137134276427925781479
  • LiangYHLiuCHLiaoSHCosynthesis of cargo-loaded hydroxyapatite/alginate core-shell nanoparticles (HAP@Alg) as pH-responsive nanovehicles by a pre-gel methodACS Appl Mater Interfaces20124126720672723151216
  • BastakotiBPHsuYCLiaoSHInorganic-organic hybrid nanoparticles with biocompatible calcium phosphate thin shells for fluorescence enhancementChem Asian J2013861301130523526653
  • McnamaraKTofailSANanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applicationsPhys Chem Chem Phys20151742279812799526024211
  • TassaCShawSYWeisslederRDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapyAcc Chem Res2011441084285221661727
  • LutzJFStillerSHothAKaufnerLPisonUCartierROne-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agentsBiomacromolecules20067113132313817096542
  • KohlerNFryxellGEZhangMA bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agentsJ Am Chem Soc2004126237206721115186157
  • MasoudiAMadaah HosseiniHRShokrgozarMAAhmadiROghabianMAThe effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agentInt J Pharm20124331–212914122579990
  • MaDGuanJDénomméeSEnrightGVeresTSimardBMultifunctional nano-architecture for biomedical applicationsChem Mater200618719201927
  • BanZBarnakovYALiFGolubaVOO’ConnoCJThe synthesis of core–shell iron@gold nanoparticles and their characterizationJ Mater Chem2005154346604662
  • ChenMYamamuroSFarrellDMajetichSAGold-coated iron nanoparticles for biomedical applicationsJ Appl Phys2003931075517553
  • ZhouTWuBXingDBio-modified Fe3O4 core/Au shell nanoparticles for targeting and multimodal imaging of cancer cellsJ Mater Chem2011222470477
  • BrullotWValevVKVerbiestTMagnetic-plasmonic nanoparticles for the life sciences: calculated optical properties of hybrid structuresNanomedicine20128555956821945901
  • ZhouHChoiSIZouFCytotoxicity and gene expression in sarcoma 180 cells in response to spiky magnetoplasmonic supraparticlesACS Appl Mater Interfaces2014622196801968925369231
  • ZhouHZouFKohKLeeJMultifunctional magnetoplasmonic nanomaterials and their biomedical applicationsJ Biomed Nanotechnol201410102921294925992424
  • EspinosaADiCRKolosnjaj-TabiJFlaudPPellegrinoTWilhelmCDuality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatmentACS Nano20161022436244626766814
  • LiYuntaoLiuJingZhongYuejiaoBiocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivoInt J Nanomedicine201162805281922131827
  • DuYZhangDLiuHLaiRThermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9BMC Biotechnol200998419804631
  • TzonevaRFaucheuxNGrothTWettability of substrata controls cell-substrate and cell-cell adhesionsBiochim Biophys Acta20071770111538154717804166
  • WongAJBignerSHBignerDDKinzlerKWHamiltonSRVogelsteinBIncreased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplificationProc Natl Acad Sci U S A19878419689969033477813
  • van den BentMJBrandesAARamplingRRandomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034J Clin Oncol20092781268127419204207
  • LassmanABRossiMRRaizerJJMolecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Clin Cancer Res200511217841785016278407
  • DokalaAThakurSSExtracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discoveryOncogene201736172337234427775071
  • HerbstRSLangerCJEpidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancersSemin Oncol200229292736
  • ChenXZhuXLiLInvestigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor IIInt J Pharm2013456249950723999222
  • JoDHKimJHLeeTGKimJHSize, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseasesNanomedicine20151171603161125989200
  • WangHZhaoXGuoCAptamer-dendrimer bioconjugates for targeted delivery of miR-34a expressing plasmid and antitumor effects in non-small cell lung cancer cellsPLoS One2015109e013913626406332
  • GuoJGaoXSuLAptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug deliveryBiomaterials201132318010802021788069
  • TaghaviSNiaAHAbnousKRamezaniMPolyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cellsInt J Pharm20175161–230131227840158